IL17A and psoriasis: In psoriasis, they contribute through two primary mechanisms: direct cytotoxicity against epidermal cells via perforin and granzyme release, and amplification of inflammation through secretion of pro-inflammatory cytokines, such as IFN-γ, IL-17, and IL-22, across multiple signaling pathways (5, 60).